ω-Conotoxin GVIA Mimetics that Bind and Inhibit Neuronal Cav2.2 Ion Channels
The neuronal voltage-gated N-type calcium channel (Cav2.2) is a validated target for the treatment of neuropathic pain. A small library of anthranilamide-derived ω-Conotoxin GVIA mimetics bearing the diphenylmethylpiperazine moiety were prepared and tested using three experimental measures of calciu...
Main Authors: | Peter J. Duggan, Aijun Yang, Irina Vetter, Jeffrey R. McArthur, Richard J. Lewis, Kellie L. Tuck, Jonathan B. Baell, Charlotte Elisabet Tranberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-10-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-3397/10/10/2349 |
Similar Items
-
Bioactive Mimetics of Conotoxins and other Venom Peptides
by: Peter J. Duggan, et al.
Published: (2015-10-01) -
Conformational ensembles of non-peptide ω-conotoxin mimetics and Ca+2 ion binding to human voltage-gated N-type calcium channel Cav2.2
by: Sameera, et al.
Published: (2020-01-01) -
Conotoxins as Tools to Understand the Physiological Function of Voltage-Gated Calcium (CaV) Channels
by: David Ramírez, et al.
Published: (2017-10-01) -
É-Conotoxins GVIA, MVIIA and CVID: SAR and Clinical Potential
by: Richard J. Lewis, et al.
Published: (2006-04-01) -
Venom Peptides as a Rich Source of Cav2.2 Channel Blockers
by: Richard J. Lewis, et al.
Published: (2013-02-01)